Works matching IS 18696953 AND DT 2020 AND VI 11 AND IP 2
Results: 16
Study Protocol for Pleiotropic Effects and Safety of Sodium–Glucose Cotransporter 2 Inhibitor Versus Sulfonylurea in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 549, doi. 10.1007/s13300-020-00762-9
- By:
- Publication type:
- Article
Cost of Managing Type 2 Diabetes Before and After Initiating Dipeptidyl Peptidase 4 Inhibitor Treatment: A Longitudinal Study Using a French Public Health Insurance Database.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 535, doi. 10.1007/s13300-020-00760-x
- By:
- Publication type:
- Article
Commentary to "Differential Effect of Hypoalbuminemia on Hypoglycemia on Type 2 Diabetes Patients Treated with Insulin Glargine 300 U/ml and Insulin Degludec" by Kawaguchi et al. Diabetes Therapy 2019.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 561, doi. 10.1007/s13300-019-00755-3
- By:
- Publication type:
- Article
Long-Term Safety and Effectiveness of Linagliptin in Japanese Patients with Type 2 Diabetes and Renal Dysfunction: a Post-Marketing Surveillance Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 523, doi. 10.1007/s13300-019-00754-4
- By:
- Publication type:
- Article
Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 411, doi. 10.1007/s13300-019-00753-5
- By:
- Publication type:
- Article
Correction to: Optimising the Benefits of SGLT2 Inhibitors for Type 1 Diabetes.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
The Short-Term Cost-Effectiveness of Once-Weekly Semaglutide Versus Once-Daily Sitagliptin and Once-Weekly Dulaglutide for the Treatment of Patients with Type 2 Diabetes: A Cost of Control Analysis in Spain.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 509, doi. 10.1007/s13300-019-00751-7
- By:
- Publication type:
- Article
Adherence to Medication, Diet and Physical Activity and the Associated Factors Amongst Patients with Type 2 Diabetes.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 479, doi. 10.1007/s13300-019-00750-8
- By:
- Publication type:
- Article
Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 495, doi. 10.1007/s13300-019-00749-1
- By:
- Publication type:
- Article
Familial Hypercholesterolaemia in a Bulgarian Population of Patients with Dyslipidaemia and Diabetes: An Observational Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 453, doi. 10.1007/s13300-019-00748-2
- By:
- Publication type:
- Article
Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 369, doi. 10.1007/s13300-019-00747-3
- By:
- Publication type:
- Article
Insulin Glargine 300 U/mL and Insulin Glulisine Treatment in Patients with Type 2 Diabetes: A Non-Interventional Study of Effectiveness in Routine Clinical Practice.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 467, doi. 10.1007/s13300-019-00746-4
- By:
- Publication type:
- Article
Clinical Inertia in Poorly Controlled Type 2 Diabetes Mellitus Patients with Obesity: An Observational Retrospective Study.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 437, doi. 10.1007/s13300-019-00745-5
- By:
- Publication type:
- Article
A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 423, doi. 10.1007/s13300-019-00744-6
- By:
- Publication type:
- Article
Insulin Therapy in Adults with Type 1 Diabetes Mellitus: a Narrative Review.
- Published in:
- Diabetes Therapy, 2020, v. 11, n. 2, p. 387, doi. 10.1007/s13300-019-00743-7
- By:
- Publication type:
- Article
Correction to: The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice